UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Estimating the health care burden of prescription opioid abuse in five European countries

ClinicoEconomics and outcomes research, 2015-01, Vol.7 (default), p.477-488

2015

Volltextzugriff (PDF)

The Suitability of End Point Designs for Health Technology Assessment in Chronic Pain Studies

Value in health, 2015-12, Vol.18 (8), p.987-993

2015

Volltextzugriff (PDF)

The Budget Impact of Biosimilar Infliximab (Remsima®) for the Treatment of Autoimmune Diseases in Five European Countries

Advances in therapy, 2015-08, Vol.32 (8), p.742-756

2015

Volltextzugriff (PDF)

Cost-Effectiveness of Take-Home Naloxone for the Prevention of Overdose Fatalities among Heroin Users in the United Kingdom

Value in health, 2018-04, Vol.21 (4), p.407-415

2018

Volltextzugriff (PDF)

Benefits, Challenges and Potential Strategies of Open Source Health Economic Models

PharmacoEconomics, 2017-01, Vol.35 (1), p.125-128

2017

Volltextzugriff (PDF)

Innovative pharmaceutical pricing agreements in five European markets: A survey of stakeholder attitudes and experience

Health policy (Amsterdam), 2018-05, Vol.122 (5), p.528-532

2018

Volltextzugriff (PDF)

The Impasse on Overall Survival in Oncology Reimbursement Decision-Making: How Can We Resolve This?

Cancer management and research, 2021-01, Vol.13, p.8457-8471

2021

Volltextzugriff (PDF)

BEACON: A Summary Framework to Overcome Potential Reimbursement Hurdles

PharmacoEconomics, 2016-10, Vol.34 (10), p.1051-1065

2016

Volltextzugriff (PDF)

When Science is Not Enough: A Framework Towards More Customer-Focused Drug Development

Advances in therapy, 2017-07, Vol.34 (7), p.1572-1583

2017

Volltextzugriff (PDF)

Use of opioid substitution therapies in the treatment of opioid use disorder: results of a UK cost-effectiveness modelling study

Journal of medical economics, 2017-07, Vol.20 (7), p.740-748

2017

Volltextzugriff (PDF)

A systematic review of health economic models of opioid agonist therapies in maintenance treatment of non-prescription opioid dependence

Addiction science & clinical practice, 2017-02, Vol.12 (1), p.6, Article 6

2017

Volltextzugriff (PDF)

Examining the association between pain severity and quality-of-life, work-productivity loss, and healthcare resource use among European adults diagnosed with pain

Journal of medical economics, 2016-09, Vol.19 (9), p.858-865

2016

Volltextzugriff (PDF)

Cost-utility analysis of an intervention designed to reduce the critical handling error of insufficient inspiratory effort

The European journal of health economics, 2018-12, Vol.19 (9), p.1303-1318

2018

Volltextzugriff (PDF)

Cost-effectiveness modeling for neuropathic pain treatments: investigating the relative importance of parameters using an open-source model

Journal of medical economics, 2018-09, Vol.21 (9), p.930-935

2018

Volltextzugriff (PDF)

Maintenance Therapy with Rituximab for Follicular Lymphoma Is Cost-Effective – A Canadian Perspective

Blood, 2006-11, Vol.108 (11), p.343-343

2006

Volltextzugriff (PDF)

1 – 15 von 15

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15)
Mit Volltextzugriff
(15)

Publikationsform

Artikel
(15)

Sprache

Englisch
(15)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Estimating the health care burden of prescription opioid abuse in five European countries

The Suitability of End Point Designs for Health Technology Assessment in Chronic Pain Studies

The Budget Impact of Biosimilar Infliximab (Remsima®) for the Treatment of Autoimmune Diseases in Five European Countries

Cost-Effectiveness of Take-Home Naloxone for the Prevention of Overdose Fatalities among Heroin Users in the United Kingdom

Benefits, Challenges and Potential Strategies of Open Source Health Economic Models

Innovative pharmaceutical pricing agreements in five European markets: A survey of stakeholder attitudes and experience

The Impasse on Overall Survival in Oncology Reimbursement Decision-Making: How Can We Resolve This?

BEACON: A Summary Framework to Overcome Potential Reimbursement Hurdles

When Science is Not Enough: A Framework Towards More Customer-Focused Drug Development

Use of opioid substitution therapies in the treatment of opioid use disorder: results of a UK cost-effectiveness modelling study

A systematic review of health economic models of opioid agonist therapies in maintenance treatment of non-prescription opioid dependence

Examining the association between pain severity and quality-of-life, work-productivity loss, and healthcare resource use among European adults diagnosed with pain

Cost-utility analysis of an intervention designed to reduce the critical handling error of insufficient inspiratory effort

Cost-effectiveness modeling for neuropathic pain treatments: investigating the relative importance of parameters using an open-source model

Maintenance Therapy with Rituximab for Follicular Lymphoma Is Cost-Effective – A Canadian Perspective

Suchergebnisse filtern